TREM2 and Alzheimer disease: Rare, heterozygous mutations of TREM2 are known to affect AD risk, including the R47H mutation, which increases AD risk several fold (Guerreiro et al., 2012; Giraldo et al., 2013; Jonsson et al., 2013; Kulkarni et al., 2021).